Pathologisch-genetisch orientierte Diabetes-Reklassifizierung

 

 Buy Article Permissions and Reprints

Abstract

Diabetes mellitus has been defined by hyperglycemia, but in addition to hyperglycemia, there are several other factors determining the clinical course and complications. We review the current classification of diabetes and recent attempts to identify new subphenotypes. Notably, there are anthropometry-pathophysiology based and genome-based subphenotyping approaches. They aim to improve the prediction of disease course and complications and could pave the way for precision medicine in the therapy of diabetes.

Publication History

Article published online:
29 April 2020

© Georg Thieme Verlag KG
Stuttgart · New York

• Literatur

• 1 Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes 2008; 26: 77-82
  CrossrefPubMedGoogle Scholar
• 2 Duckworth W, Abraira C, Moritz T. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139
  CrossrefPubMedGoogle Scholar
• 3 Patel A, MacMahon S. ADVANCE Collaborative Group. et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572
  CrossrefPubMedGoogle Scholar
• 4 Gerstein HC, Miller ME. Action to Control Cardiovascular Risk in Diabetes Study Group. et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559
  CrossrefPubMedGoogle Scholar
• 5 Davidson MB. Diagnosing diabetes with glucose criteria: worshipping a false god. Diabetes Care 2011; 34: 524-526
  CrossrefPubMedGoogle Scholar
• 6 Hodson R. Precision medicine. Nature 2016; 537: S49-S49
  PubMedGoogle Scholar
• 7 Häring HU. Novel phenotypes of prediabetes?. Diabetologia 2016; 59: 1806-1818
  CrossrefPubMedGoogle Scholar
• 8 Stefan N, Fritsche A, Schick F. et al. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol 2016; 4: 789-798
  CrossrefPubMedGoogle Scholar
• 9 Stefan N, Staiger H, Wagner R. et al. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia 2015; 58: 1-8
  PubMedGoogle Scholar
• 10 Li L, Cheng WY, Glicksberg BS. et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med 2015; 7: 311ra174
  CrossrefPubMedGoogle Scholar
• 11 Ahlqvist E, Storm P, Käräjämäki A. et al Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol; 2018 Im Internet: http://www.thelancet.com/journals/landia/article/PIIS2213–8587(18)30051–2/abstract
  PubMedGoogle Scholar
• 12 Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2192
  CrossrefPubMedGoogle Scholar
• 13 Zaharia OP, Strassburger K, Strom A. et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 2019; 7: 684-694
  CrossrefPubMedGoogle Scholar
• 14 Thorn LM, Forsblom C, Wadén J. et al. Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes. Diabetes Care 2009; 32: 950-952
  CrossrefPubMedGoogle Scholar
• 15 Welsh GI, Hale LJ, Eremina V. et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 2010; 12: 329-340
  PubMedGoogle Scholar
• 16 Thamer C, Machann J, Stefan N. et al. High Visceral Fat Mass and High Liver Fat Are Associated with Resistance to Lifestyle Intervention. Obesity 2007; 15: 531-538
  CrossrefPubMedGoogle Scholar
• 17 Wagner R, Machann J, Lehmann R. et al. Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes. Diabetologia 2012; 55: 2054-2058
  CrossrefPubMedGoogle Scholar
• 18 Wagner R, Machann J, Guthoff M. et al. The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A. Sci Rep 2017; 7: 2261
  CrossrefPubMedGoogle Scholar
• 19 Dennis JM, Shields BM, Henley WE. et al Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol 2019; 7 (06) 442-451 . Im Internet: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30087-7/abstract (Stand: 03.03.2020)
  Google Scholar
• 20 Stidsen JV, Henriksen JE, Olsen MH. et al. Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool. Diabetes Metab Res Rev 2018; 0: e3005
  PubMedGoogle Scholar
• 21 Chatterjee S, Davies MJ. Accurate diagnosis of diabetes mellitus and new paradigms of classification. Nat Rev Endocrinol 2018; 14: 386-387 . Im Internet: https://www.nature.com/articles/s41574-018-0025-1 (Stand: 03.03.2020)
  CrossrefPubMedGoogle Scholar
• 22 Franks PW, Merino J. Gene-lifestyle interplay in type 2 diabetes. Curr Opin Genet Dev 2018; 50: 35-40
  CrossrefPubMedGoogle Scholar
• 23 Archer E. The Childhood obesity epidemic as a result of nongenetic evolution: the maternal resources hypothesis. Mayo Clin Proc 2015; 90: 77-92
  CrossrefPubMedGoogle Scholar
• 24 Almgren P, Lehtovirta M, Isomaa B. et al. Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 2011; 54: 2811-2819
  CrossrefPubMedGoogle Scholar
• 25 Wagner R, Staiger H. Genetik des Typ-2-Diabetes. Diabetol 2019; 15: 267-277
  PubMedGoogle Scholar
• 26 Mahajan A, Wessel J, Willems SM. et al. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat Genet 2018; 50: 559
  CrossrefPubMedGoogle Scholar
• 27 Shepherd MH, Shields BM, Hudson M. et al. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Diabetologia 2018; 61: 2520-2527
  CrossrefPubMedGoogle Scholar
• 28 Dotta F, Fondelli C, Di Mario U. Type 1 diabetes mellitus as a polygenic multifactorial disease: immunopathogenic mechanisms of beta-cell destruction. Acta Biomed 2005; 76: 14-18
  PubMedGoogle Scholar
• 29 Barrett JC, Clayton DG, Concannon P. et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703-707
  CrossrefPubMedGoogle Scholar
• 30 Gloyn AL, Drucker DJ. Precision medicine in the management of type 2 diabetes. Lancet Diabetes Endocrinol 2018; 6, 11: 891-900 . Im Internet: http://www.sciencedirect.com/science/article/pii/S2213858718300524 (Stand: 03.03.2020)
  CrossrefPubMedGoogle Scholar
• 31 Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet 2018; 19: 581
  CrossrefPubMedGoogle Scholar
• 32 Khera AV, Chaffin M, Aragam KG. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 2018; 50: 1219-1224
  CrossrefPubMedGoogle Scholar
• 33 Bonifacio E, Beyerlein A, Hippich M. TEDDY Study Group. et al. Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children. PLoS Med 2018; 15: e1002548
  CrossrefPubMedGoogle Scholar
• 34 Oram RA, Patel K, Hill A. et al. A Type 1 Diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care 2016; 39: 337-344
  CrossrefPubMedGoogle Scholar
• 35 Thomas NJ, Jones SE, Weedon MN. et al Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol 2017; 6 (02) 122-129 . Im Internet: https://www.sciencedirect.com/science/article/pii/S2213858717303625 (Stand: 03.03.2020)
  PubMedGoogle Scholar
• 36 Johnson MB, Patel KA, De Franco E. et al. A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes. Diabetologia 2018; 61: 862-869
  CrossrefPubMedGoogle Scholar
• 37 Wagner R, Häring HU, Fritsche A. Phänotypen des Prädiabetes und des Typ-2-Diabetes. Dtsch Med Wochenschr 2014; 139: 1109-1113
  Article in Thieme ConnectPubMedGoogle Scholar
• 38 Udler MS, Kim J, von Grotthuss M. et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. PLoS Med 2018; 15: e1002654
  CrossrefPubMedGoogle Scholar
• 39 Ji Y, Yiorkas AM, Frau F. et al. Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 2019; 68: 207-219
  CrossrefPubMedGoogle Scholar
• 40 World Health Organization. Classification of diabetes mellitus 2019. https://apps.who.int/iris/bitstream/handle/10665/325182/9789241515702-eng.pdf?sequence=1&isAllowed=y
  PubMedGoogle Scholar